Kelyniam Global announced that it has hired Ross Bjella as Chairman and Chief Executive Officer. The company had recently appointed Chris Breault as Chief Operating Officer after the former President, Tennyson Anthony, left the company in April of this year. The company has also appointed Mark V. Smith, MD., as Vice President of Sales and Business Development.

Ross Bjella previously worked at the formation of KLYG. Ross is the current CEO of Alithias, Inc. He previously served as the CEO of DDN. Dr. Smith is a neurosurgeon and biomedical engineer who has worked closely with Kelyniam as a customer and advisor since 2012.

Dr. Smith accepted the position of Vice President of Sales and Business Development in early September after successfully serving as a consultant in that role since last May 2017. Dr. Smith brings over 20 years of clinical neurosurgery experience to the company.